Trial intelligence / Profile preview

PANVAC-VF in metastatic pancreatic cancer

NCT00088660Phase 3Unknown

Sponsor
Therion Biologics
Start
Jun 2004
Modality
Prophylactic Vaccines, DNA Vaccines
Countries
1
01

Overview

A Phase 3 trial of PANVAC-VF in pancreatic cancer (PC), sponsored by Therion Biologics. Status: unknown.

02

Drugs

PANVAC-VF
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT00088660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00088660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call